Jungo Yasuda

Jungo Yasuda

Auto-generated profile, based on publicly available information

Jungo Yasuda

Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2018 in The International Journal of Medical Robotics and Computer Assisted Surgery
Verified
Journal Article
Closed access
PDF file
JYJungo Yasuda
Jungo Yasuda
TOTomoyoshi Okamoto
Tomoyoshi Okamoto
SOShinji Onda
Shinji Onda
YFYasuro Futagawa
Yasuro Futagawa
KYKatsuhiko Yanaga
Katsuhiko Yanaga
AHAsaki Hattori
Asaki Hattori

1 January 2021 in Pancreatology
Verified
Journal Article
Closed access
KFKenei Furukawa
Kenei Furukawa
TGTakeshi Gocho
Takeshi Gocho
TSTaro Sakamoto
Taro Sakamoto
MTMasashi Tsunematsu
Masashi Tsunematsu
KHKoichiro Haruki
Koichiro Haruki
TIToru Ikegami
Toru Ikegami

14 March 2022 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
YIYosuke Igarashi
Yosuke Igarashi
TGTakeshi Gocho
Takeshi Gocho
TTTomohiko Taniai
Tomohiko Taniai
TUTadashi Uwagawa
Tadashi Uwagawa
RHRyoga Hamura
Ryoga Hamura
TIToru Ikegami
Toru Ikegami
Background: Undifferentiated carcinoma with osteoclast-like giant cells (UCOGCs) is a rare subtype of pancreatic cancer (PC), and its clinicopathological characteristics are still unclear. Herein, we report a case of initially unresectable UCOGC that was successfully resected after FOLFIRINOX therapy. Case presentation: A 63-year-old man was referred to us for evaluation of a pancreatic mass detected by computed tomography (CT) during a medical checkup. Computed tomography showed a 7.5-cm tumor located in the pancreatic head and body, which involved the common hepatic artery (CHA), gastroduodenal artery (GDA), and main portal vein (PV) with tumor thrombus. UCOGC was suspected by endoscopic ultrasonography-guided fine needle aspiration, and the patient was diagnosed with unresectable locally advanced pancreatic cancer. After ten cycles of FOLFIRINOX, the tumor size decreased to 3 cm and the tumor thrombus in the main portal trunk had disappeared in the follow-up CT scan. However, the patient experienced severe adverse drug reactions, including neutropenia and liver dysfunction. Therefore, we performed pancreatoduodenectomy with portal vein resection. The pathological diagnosis was UCOGC with a negative tumor margin. He was treated with FOLFIRINOX, and remains recurrence-free for 6 months after surgery. Conclusions: We experienced a case undergoing conversion surgery for unresectable UCOGC, which resulted in R0 resection. FOLFIRINOX could be a possible regimen to achieve conversion surgery for UCOGC.

4 April 2023 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
SOShinji Onda
Shinji Onda
KHKoichiro Haruki
Koichiro Haruki
KFKenei Furukawa
Kenei Furukawa
JYJungo Yasuda
Jungo Yasuda
NONorimitsu Okui
Norimitsu Okui
TIToru Ikegami
Toru Ikegami

23 October 2018 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
JYJungo Yasuda
Jungo Yasuda
SOShinji Onda
Shinji Onda
HSHironori Shiozaki
Hironori Shiozaki
TGTakeshi Gocho
Takeshi Gocho
HSHiroaki Shiba
Hiroaki Shiba
KYKatsuhiko Yanaga
Katsuhiko Yanaga
Dermatomyositis (DM) is often found in conjunction with malignant tumors such as lung, cervical, and breast cancer. However, the association with intrahepatic cholangiocarcinoma (ICC) is extremely rare. Moreover, to our knowledge, there have been no previous reports of DM discovered because of exacerbation of DM. Our case was a 44-year-old female with dry cough, myalgia, and arthralgia. We performed hepatic resection for intrahepatic ICC. She was diagnosed with DM, and combination treatment with prednisolone and tacrolimus was started. During outpatient visits, her symptoms worsened, and she was hospitalized due to deterioration of her primary disease. On detailed examination, a malignant lesion in the liver was discovered. After operation, the symptoms of DM remain stable by taking prednisolone and tacrolimus. The patient was suspected to have paraneoplastic syndrome, which was discovered due to the exacerbation of the DM that was caused by the intrahepatic ICC.

1 December 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
TGTakeshi Gocho
Takeshi Gocho
KFKenei Furukawa
Kenei Furukawa
HSHironori Shiozaki
Hironori Shiozaki
JYJungo Yasuda
Jungo Yasuda
YSYoshihiro Shirai
Yoshihiro Shirai
TIToru Ikegami
Toru Ikegami
We recently enjoyed the article entitled published from Kyoto group (1) with much interest. They evaluated muscle mass index (MSI) and intramuscular adipose tissue content (IMAC), representing muscular mass and quality respectively, and fond that high muscularity donor with higher SMI and lower IMAC for age-adjusted values was the independent positive factor for survival.